FEED
ENvue Medical, Inc.
NASDAQ · Healthcare · Medical - Specialties · US
$4.01
+4.70%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
Market Cap
$3.70M
MomentumView details →
1D Return
+4.70%
YTD Return
+71.90%
RSI (14)
41.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.3x
Market Cap
$3.70M
RSI (14)
41.7
MomentumView details →
1D Return
+4.70%
YTD Return
+71.90%
Similar companies
Latest newsMore news →
ENvue Medical signed a multi-year exclusive distribution agreement with Peak Medical for UroShield across the United Kingdom and Republic of Ireland, with minimum purchase commitments of approximately $2.6 million.17d agoENvue Medical entered into a securities purchase agreement with an institutional investor for an equity facility of up to $50 million to support commercial growth, technology expansion, and strategic acquisitions.23d agoENvue Medical, Inc. amended its Series H Purchase Agreement with the same investor, increasing the total Additional Investment Rights and requiring the investor to exercise a minimum amount of rights following shareholder approval.24d ago